Syntropic Medical's innovative device utilizes light-based brain stimulation to create a drug-free treatment for depression, focusing on enhancing neuroplasticity and reconfiguring neural connections.
The technology addresses a critical gap in mental health care where conventional antidepressants fail, providing non-invasive stimulation that can remodel brain structures associated with depressive disorders.
By utilizing flickering lights aimed at microglial cells, Syntropic's approach promotes brain health without the side effects linked to standard antidepressants, offering a safer long-term option.
Securing €1.1 million in funding from the Austrian Research Promotion Agency signifies validation of Syntropic’s science and its promise in revolutionizing depression treatment methodologies.
[
Collection
]
[
|
...
]